+1 347 708 0418
Gynaecological Cancer Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Gynaecological Cancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Alkylating Agent
Plant Alkaloid
Anthracyclines
Antitumor Antibiotic
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
E-commerce
By Company
Roche Holdings
AstraZeneca
Sanofi
Eli Lilly
Pfizer
Takeda Pharmaceuticals
Bristol-Myers Squibb
Merck
Dr Reddys Laboratories
Johnson & Johnson
GlaxoSmithKline
Apotex
Hoffmann-La Roche
Novartis
Teva Pharmaceutical
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Gynaecological Cancer Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Gynaecological Cancer Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Alkylating Agent
1.2.3 Plant Alkaloid
1.2.4 Anthracyclines
1.2.5 Antitumor Antibiotic
1.2.6 Others
1.3 Market by Application
1.3.1 Global Gynaecological Cancer Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 E-commerce
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Gynaecological Cancer Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Gynaecological Cancer Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Gynaecological Cancer Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Gynaecological Cancer Drugs Sales by Region
2.4.1 Global Gynaecological Cancer Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Gynaecological Cancer Drugs by Region (2023-2028)
2.5 Global Gynaecological Cancer Drugs Revenue by Region
2.5.1 Global Gynaecological Cancer Drugs Revenue by Region (2017-2022)
2.5.2 Global Gynaecological Cancer Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Gynaecological Cancer Drugs Sales by Manufacturers
3.1.1 Global Top Gynaecological Cancer Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Gynaecological Cancer Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gynaecological Cancer Drugs in 2021
3.2 Global Gynaecological Cancer Drugs Revenue by Manufacturers
3.2.1 Global Gynaecological Cancer Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Gynaecological Cancer Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Gynaecological Cancer Drugs Revenue in 2021
3.3 Global Gynaecological Cancer Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Gynaecological Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Gynaecological Cancer Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Gynaecological Cancer Drugs Sales by Type
4.1.1 Global Gynaecological Cancer Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Gynaecological Cancer Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Gynaecological Cancer Drugs Sales Market Share by Type (2017-2028)
4.2 Global Gynaecological Cancer Drugs Revenue by Type
4.2.1 Global Gynaecological Cancer Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Gynaecological Cancer Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Gynaecological Cancer Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Gynaecological Cancer Drugs Price by Type
4.3.1 Global Gynaecological Cancer Drugs Price by Type (2017-2022)
4.3.2 Global Gynaecological Cancer Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Gynaecological Cancer Drugs Sales by Application
5.1.1 Global Gynaecological Cancer Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Gynaecological Cancer Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Gynaecological Cancer Drugs Sales Market Share by Application (2017-2028)
5.2 Global Gynaecological Cancer Drugs Revenue by Application
5.2.1 Global Gynaecological Cancer Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Gynaecological Cancer Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Gynaecological Cancer Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Gynaecological Cancer Drugs Price by Application
5.3.1 Global Gynaecological Cancer Drugs Price by Application (2017-2022)
5.3.2 Global Gynaecological Cancer Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Gynaecological Cancer Drugs Market Size by Type
6.1.1 North America Gynaecological Cancer Drugs Sales by Type (2017-2028)
6.1.2 North America Gynaecological Cancer Drugs Revenue by Type (2017-2028)
6.2 North America Gynaecological Cancer Drugs Market Size by Application
6.2.1 North America Gynaecological Cancer Drugs Sales by Application (2017-2028)
6.2.2 North America Gynaecological Cancer Drugs Revenue by Application (2017-2028)
6.3 North America Gynaecological Cancer Drugs Market Size by Country
6.3.1 North America Gynaecological Cancer Drugs Sales by Country (2017-2028)
6.3.2 North America Gynaecological Cancer Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Gynaecological Cancer Drugs Market Size by Type
7.1.1 Europe Gynaecological Cancer Drugs Sales by Type (2017-2028)
7.1.2 Europe Gynaecological Cancer Drugs Revenue by Type (2017-2028)
7.2 Europe Gynaecological Cancer Drugs Market Size by Application
7.2.1 Europe Gynaecological Cancer Drugs Sales by Application (2017-2028)
7.2.2 Europe Gynaecological Cancer Drugs Revenue by Application (2017-2028)
7.3 Europe Gynaecological Cancer Drugs Market Size by Country
7.3.1 Europe Gynaecological Cancer Drugs Sales by Country (2017-2028)
7.3.2 Europe Gynaecological Cancer Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Gynaecological Cancer Drugs Market Size by Type
8.1.1 Asia Pacific Gynaecological Cancer Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Gynaecological Cancer Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Gynaecological Cancer Drugs Market Size by Application
8.2.1 Asia Pacific Gynaecological Cancer Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Gynaecological Cancer Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Gynaecological Cancer Drugs Market Size by Region
8.3.1 Asia Pacific Gynaecological Cancer Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Gynaecological Cancer Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Gynaecological Cancer Drugs Market Size by Type
9.1.1 Latin America Gynaecological Cancer Drugs Sales by Type (2017-2028)
9.1.2 Latin America Gynaecological Cancer Drugs Revenue by Type (2017-2028)
9.2 Latin America Gynaecological Cancer Drugs Market Size by Application
9.2.1 Latin America Gynaecological Cancer Drugs Sales by Application (2017-2028)
9.2.2 Latin America Gynaecological Cancer Drugs Revenue by Application (2017-2028)
9.3 Latin America Gynaecological Cancer Drugs Market Size by Country
9.3.1 Latin America Gynaecological Cancer Drugs Sales by Country (2017-2028)
9.3.2 Latin America Gynaecological Cancer Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Gynaecological Cancer Drugs Market Size by Type
10.1.1 Middle East and Africa Gynaecological Cancer Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Gynaecological Cancer Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Gynaecological Cancer Drugs Market Size by Application
10.2.1 Middle East and Africa Gynaecological Cancer Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Gynaecological Cancer Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Gynaecological Cancer Drugs Market Size by Country
10.3.1 Middle East and Africa Gynaecological Cancer Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Gynaecological Cancer Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Roche Holdings
11.1.1 Roche Holdings Corporation Information
11.1.2 Roche Holdings Overview
11.1.3 Roche Holdings Gynaecological Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Roche Holdings Gynaecological Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Roche Holdings Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca Gynaecological Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AstraZeneca Gynaecological Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Gynaecological Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi Gynaecological Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Recent Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Corporation Information
11.4.2 Eli Lilly Overview
11.4.3 Eli Lilly Gynaecological Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Eli Lilly Gynaecological Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Eli Lilly Recent Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Gynaecological Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Pfizer Gynaecological Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 Takeda Pharmaceuticals
11.6.1 Takeda Pharmaceuticals Corporation Information
11.6.2 Takeda Pharmaceuticals Overview
11.6.3 Takeda Pharmaceuticals Gynaecological Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Takeda Pharmaceuticals Gynaecological Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Takeda Pharmaceuticals Recent Developments
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Corporation Information
11.7.2 Bristol-Myers Squibb Overview
11.7.3 Bristol-Myers Squibb Gynaecological Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Bristol-Myers Squibb Gynaecological Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bristol-Myers Squibb Recent Developments
11.8 Merck
11.8.1 Merck Corporation Information
11.8.2 Merck Overview
11.8.3 Merck Gynaecological Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Merck Gynaecological Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Merck Recent Developments
11.9 Dr Reddys Laboratories
11.9.1 Dr Reddys Laboratories Corporation Information
11.9.2 Dr Reddys Laboratories Overview
11.9.3 Dr Reddys Laboratories Gynaecological Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Dr Reddys Laboratories Gynaecological Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Dr Reddys Laboratories Recent Developments
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Corporation Information
11.10.2 Johnson & Johnson Overview
11.10.3 Johnson & Johnson Gynaecological Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Johnson & Johnson Gynaecological Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Johnson & Johnson Recent Developments
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Corporation Information
11.11.2 GlaxoSmithKline Overview
11.11.3 GlaxoSmithKline Gynaecological Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 GlaxoSmithKline Gynaecological Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 GlaxoSmithKline Recent Developments
11.12 Apotex
11.12.1 Apotex Corporation Information
11.12.2 Apotex Overview
11.12.3 Apotex Gynaecological Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Apotex Gynaecological Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Apotex Recent Developments
11.13 Hoffmann-La Roche
11.13.1 Hoffmann-La Roche Corporation Information
11.13.2 Hoffmann-La Roche Overview
11.13.3 Hoffmann-La Roche Gynaecological Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Hoffmann-La Roche Gynaecological Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Hoffmann-La Roche Recent Developments
11.14 Novartis
11.14.1 Novartis Corporation Information
11.14.2 Novartis Overview
11.14.3 Novartis Gynaecological Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Novartis Gynaecological Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Novartis Recent Developments
11.15 Teva Pharmaceutical
11.15.1 Teva Pharmaceutical Corporation Information
11.15.2 Teva Pharmaceutical Overview
11.15.3 Teva Pharmaceutical Gynaecological Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Teva Pharmaceutical Gynaecological Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Teva Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Gynaecological Cancer Drugs Industry Chain Analysis
12.2 Gynaecological Cancer Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Gynaecological Cancer Drugs Production Mode & Process
12.4 Gynaecological Cancer Drugs Sales and Marketing
12.4.1 Gynaecological Cancer Drugs Sales Channels
12.4.2 Gynaecological Cancer Drugs Distributors
12.5 Gynaecological Cancer Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Gynaecological Cancer Drugs Industry Trends
13.2 Gynaecological Cancer Drugs Market Drivers
13.3 Gynaecological Cancer Drugs Market Challenges
13.4 Gynaecological Cancer Drugs Market Restraints
14 Key Findings in The Global Gynaecological Cancer Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Gynaecological Cancer Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Alkylating Agent
Table 3. Major Manufacturers of Plant Alkaloid
Table 4. Major Manufacturers of Anthracyclines
Table 5. Major Manufacturers of Antitumor Antibiotic
Table 6. Major Manufacturers of Others
Table 7. Global Gynaecological Cancer Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Gynaecological Cancer Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Gynaecological Cancer Drugs Sales by Region (2017-2022) & (Kg)
Table 10. Global Gynaecological Cancer Drugs Sales Market Share by Region (2017-2022)
Table 11. Global Gynaecological Cancer Drugs Sales by Region (2023-2028) & (Kg)
Table 12. Global Gynaecological Cancer Drugs Sales Market Share by Region (2023-2028)
Table 13. Global Gynaecological Cancer Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Gynaecological Cancer Drugs Revenue Market Share by Region (2017-2022)
Table 15. Global Gynaecological Cancer Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Gynaecological Cancer Drugs Revenue Market Share by Region (2023-2028)
Table 17. Global Gynaecological Cancer Drugs Sales by Manufacturers (2017-2022) & (Kg)
Table 18. Global Gynaecological Cancer Drugs Sales Share by Manufacturers (2017-2022)
Table 19. Global Gynaecological Cancer Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Gynaecological Cancer Drugs Revenue Share by Manufacturers (2017-2022)
Table 21. Gynaecological Cancer Drugs Price by Manufacturers (2017-2022) &(USD/Kg)
Table 22. Global Gynaecological Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Gynaecological Cancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gynaecological Cancer Drugs as of 2021)
Table 24. Gynaecological Cancer Drugs Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Gynaecological Cancer Drugs Product Offered
Table 26. Date of Manufacturers Enter into Gynaecological Cancer Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Gynaecological Cancer Drugs Sales by Type (2017-2022) & (Kg)
Table 29. Global Gynaecological Cancer Drugs Sales by Type (2023-2028) & (Kg)
Table 30. Global Gynaecological Cancer Drugs Sales Share by Type (2017-2022)
Table 31. Global Gynaecological Cancer Drugs Sales Share by Type (2023-2028)
Table 32. Global Gynaecological Cancer Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Gynaecological Cancer Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Gynaecological Cancer Drugs Revenue Share by Type (2017-2022)
Table 35. Global Gynaecological Cancer Drugs Revenue Share by Type (2023-2028)
Table 36. Gynaecological Cancer Drugs Price by Type (2017-2022) & (USD/Kg)
Table 37. Global Gynaecological Cancer Drugs Price Forecast by Type (2023-2028) & (USD/Kg)
Table 38. Global Gynaecological Cancer Drugs Sales by Application (2017-2022) & (Kg)
Table 39. Global Gynaecological Cancer Drugs Sales by Application (2023-2028) & (Kg)
Table 40. Global Gynaecological Cancer Drugs Sales Share by Application (2017-2022)
Table 41. Global Gynaecological Cancer Drugs Sales Share by Application (2023-2028)
Table 42. Global Gynaecological Cancer Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Gynaecological Cancer Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Gynaecological Cancer Drugs Revenue Share by Application (2017-2022)
Table 45. Global Gynaecological Cancer Drugs Revenue Share by Application (2023-2028)
Table 46. Gynaecological Cancer Drugs Price by Application (2017-2022) & (USD/Kg)
Table 47. Global Gynaecological Cancer Drugs Price Forecast by Application (2023-2028) & (USD/Kg)
Table 48. North America Gynaecological Cancer Drugs Sales by Type (2017-2022) & (Kg)
Table 49. North America Gynaecological Cancer Drugs Sales by Type (2023-2028) & (Kg)
Table 50. North America Gynaecological Cancer Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Gynaecological Cancer Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Gynaecological Cancer Drugs Sales by Application (2017-2022) & (Kg)
Table 53. North America Gynaecological Cancer Drugs Sales by Application (2023-2028) & (Kg)
Table 54. North America Gynaecological Cancer Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Gynaecological Cancer Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Gynaecological Cancer Drugs Sales by Country (2017-2022) & (Kg)
Table 57. North America Gynaecological Cancer Drugs Sales by Country (2023-2028) & (Kg)
Table 58. North America Gynaecological Cancer Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Gynaecological Cancer Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Gynaecological Cancer Drugs Sales by Type (2017-2022) & (Kg)
Table 61. Europe Gynaecological Cancer Drugs Sales by Type (2023-2028) & (Kg)
Table 62. Europe Gynaecological Cancer Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Gynaecological Cancer Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Gynaecological Cancer Drugs Sales by Application (2017-2022) & (Kg)
Table 65. Europe Gynaecological Cancer Drugs Sales by Application (2023-2028) & (Kg)
Table 66. Europe Gynaecological Cancer Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Gynaecological Cancer Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Gynaecological Cancer Drugs Sales by Country (2017-2022) & (Kg)
Table 69. Europe Gynaecological Cancer Drugs Sales by Country (2023-2028) & (Kg)
Table 70. Europe Gynaecological Cancer Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Gynaecological Cancer Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Gynaecological Cancer Drugs Sales by Type (2017-2022) & (Kg)
Table 73. Asia Pacific Gynaecological Cancer Drugs Sales by Type (2023-2028) & (Kg)
Table 74. Asia Pacific Gynaecological Cancer Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Gynaecological Cancer Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Gynaecological Cancer Drugs Sales by Application (2017-2022) & (Kg)
Table 77. Asia Pacific Gynaecological Cancer Drugs Sales by Application (2023-2028) & (Kg)
Table 78. Asia Pacific Gynaecological Cancer Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Gynaecological Cancer Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Gynaecological Cancer Drugs Sales by Region (2017-2022) & (Kg)
Table 81. Asia Pacific Gynaecological Cancer Drugs Sales by Region (2023-2028) & (Kg)
Table 82. Asia Pacific Gynaecological Cancer Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Gynaecological Cancer Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Gynaecological Cancer Drugs Sales by Type (2017-2022) & (Kg)
Table 85. Latin America Gynaecological Cancer Drugs Sales by Type (2023-2028) & (Kg)
Table 86. Latin America Gynaecological Cancer Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Gynaecological Cancer Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Gynaecological Cancer Drugs Sales by Application (2017-2022) & (Kg)
Table 89. Latin America Gynaecological Cancer Drugs Sales by Application (2023-2028) & (Kg)
Table 90. Latin America Gynaecological Cancer Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Gynaecological Cancer Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Gynaecological Cancer Drugs Sales by Country (2017-2022) & (Kg)
Table 93. Latin America Gynaecological Cancer Drugs Sales by Country (2023-2028) & (Kg)
Table 94. Latin America Gynaecological Cancer Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Gynaecological Cancer Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Gynaecological Cancer Drugs Sales by Type (2017-2022) & (Kg)
Table 97. Middle East and Africa Gynaecological Cancer Drugs Sales by Type (2023-2028) & (Kg)
Table 98. Middle East and Africa Gynaecological Cancer Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Gynaecological Cancer Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Gynaecological Cancer Drugs Sales by Application (2017-2022) & (Kg)
Table 101. Middle East and Africa Gynaecological Cancer Drugs Sales by Application (2023-2028) & (Kg)
Table 102. Middle East and Africa Gynaecological Cancer Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Gynaecological Cancer Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Gynaecological Cancer Drugs Sales by Country (2017-2022) & (Kg)
Table 105. Middle East and Africa Gynaecological Cancer Drugs Sales by Country (2023-2028) & (Kg)
Table 106. Middle East and Africa Gynaecological Cancer Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Gynaecological Cancer Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 108. Roche Holdings Corporation Information
Table 109. Roche Holdings Description and Major Businesses
Table 110. Roche Holdings Gynaecological Cancer Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 111. Roche Holdings Gynaecological Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Roche Holdings Recent Developments
Table 113. AstraZeneca Corporation Information
Table 114. AstraZeneca Description and Major Businesses
Table 115. AstraZeneca Gynaecological Cancer Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 116. AstraZeneca Gynaecological Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. AstraZeneca Recent Developments
Table 118. Sanofi Corporation Information
Table 119. Sanofi Description and Major Businesses
Table 120. Sanofi Gynaecological Cancer Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 121. Sanofi Gynaecological Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Sanofi Recent Developments
Table 123. Eli Lilly Corporation Information
Table 124. Eli Lilly Description and Major Businesses
Table 125. Eli Lilly Gynaecological Cancer Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 126. Eli Lilly Gynaecological Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Eli Lilly Recent Developments
Table 128. Pfizer Corporation Information
Table 129. Pfizer Description and Major Businesses
Table 130. Pfizer Gynaecological Cancer Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 131. Pfizer Gynaecological Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Pfizer Recent Developments
Table 133. Takeda Pharmaceuticals Corporation Information
Table 134. Takeda Pharmaceuticals Description and Major Businesses
Table 135. Takeda Pharmaceuticals Gynaecological Cancer Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 136. Takeda Pharmaceuticals Gynaecological Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Takeda Pharmaceuticals Recent Developments
Table 138. Bristol-Myers Squibb Corporation Information
Table 139. Bristol-Myers Squibb Description and Major Businesses
Table 140. Bristol-Myers Squibb Gynaecological Cancer Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 141. Bristol-Myers Squibb Gynaecological Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Bristol-Myers Squibb Recent Developments
Table 143. Merck Corporation Information
Table 144. Merck Description and Major Businesses
Table 145. Merck Gynaecological Cancer Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 146. Merck Gynaecological Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Merck Recent Developments
Table 148. Dr Reddys Laboratories Corporation Information
Table 149. Dr Reddys Laboratories Description and Major Businesses
Table 150. Dr Reddys Laboratories Gynaecological Cancer Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 151. Dr Reddys Laboratories Gynaecological Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Dr Reddys Laboratories Recent Developments
Table 153. Johnson & Johnson Corporation Information
Table 154. Johnson & Johnson Description and Major Businesses
Table 155. Johnson & Johnson Gynaecological Cancer Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 156. Johnson & Johnson Gynaecological Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Johnson & Johnson Recent Developments
Table 158. GlaxoSmithKline Corporation Information
Table 159. GlaxoSmithKline Description and Major Businesses
Table 160. GlaxoSmithKline Gynaecological Cancer Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 161. GlaxoSmithKline Gynaecological Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. GlaxoSmithKline Recent Developments
Table 163. Apotex Corporation Information
Table 164. Apotex Description and Major Businesses
Table 165. Apotex Gynaecological Cancer Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 166. Apotex Gynaecological Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Apotex Recent Developments
Table 168. Hoffmann-La Roche Corporation Information
Table 169. Hoffmann-La Roche Description and Major Businesses
Table 170. Hoffmann-La Roche Gynaecological Cancer Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 171. Hoffmann-La Roche Gynaecological Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Hoffmann-La Roche Recent Developments
Table 173. Novartis Corporation Information
Table 174. Novartis Description and Major Businesses
Table 175. Novartis Gynaecological Cancer Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 176. Novartis Gynaecological Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Novartis Recent Developments
Table 178. Teva Pharmaceutical Corporation Information
Table 179. Teva Pharmaceutical Description and Major Businesses
Table 180. Teva Pharmaceutical Gynaecological Cancer Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 181. Teva Pharmaceutical Gynaecological Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 182. Teva Pharmaceutical Recent Developments
Table 183. Key Raw Materials Lists
Table 184. Raw Materials Key Suppliers Lists
Table 185. Gynaecological Cancer Drugs Distributors List
Table 186. Gynaecological Cancer Drugs Customers List
Table 187. Gynaecological Cancer Drugs Market Trends
Table 188. Gynaecological Cancer Drugs Market Drivers
Table 189. Gynaecological Cancer Drugs Market Challenges
Table 190. Gynaecological Cancer Drugs Market Restraints
Table 191. Research Programs/Design for This Report
Table 192. Key Data Information from Secondary Sources
Table 193. Key Data Information from Primary Sources
List of Figures
Figure 1. Gynaecological Cancer Drugs Product Picture
Figure 3. Global Gynaecological Cancer Drugs Market Share by Type in 2021 & 2028
Figure 3. Alkylating Agent Product Picture
Figure 4. Plant Alkaloid Product Picture
Figure 5. Anthracyclines Product Picture
Figure 6. Antitumor Antibiotic Product Picture
Figure 7. Others Product Picture
Figure 8. Global Gynaecological Cancer Drugs Market Share by Application in 2021 & 2028
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. E-commerce
Figure 12. Gynaecological Cancer Drugs Report Years Considered
Figure 13. Global Gynaecological Cancer Drugs Sales 2017-2028 (Kg)
Figure 14. Global Gynaecological Cancer Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Gynaecological Cancer Drugs Revenue 2017-2028 (US$ Million)
Figure 16. Global Gynaecological Cancer Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Gynaecological Cancer Drugs Sales Market Share by Region (2017-2022)
Figure 18. Global Gynaecological Cancer Drugs Sales Market Share by Region (2023-2028)
Figure 19. North America Gynaecological Cancer Drugs Sales YoY (2017-2028) & (Kg)
Figure 20. North America Gynaecological Cancer Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Gynaecological Cancer Drugs Sales YoY (2017-2028) & (Kg)
Figure 22. Europe Gynaecological Cancer Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Gynaecological Cancer Drugs Sales YoY (2017-2028) & (Kg)
Figure 24. Asia-Pacific Gynaecological Cancer Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Gynaecological Cancer Drugs Sales YoY (2017-2028) & (Kg)
Figure 26. Latin America Gynaecological Cancer Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Gynaecological Cancer Drugs Sales YoY (2017-2028) & (Kg)
Figure 28. Middle East & Africa Gynaecological Cancer Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Gynaecological Cancer Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Gynaecological Cancer Drugs in the World: Market Share by Gynaecological Cancer Drugs Revenue in 2021
Figure 31. Global Gynaecological Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Gynaecological Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 33. Global Gynaecological Cancer Drugs Revenue Market Share by Type (2017-2028)
Figure 34. Global Gynaecological Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 35. Global Gynaecological Cancer Drugs Revenue Market Share by Application (2017-2028)
Figure 36. North America Gynaecological Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 37. North America Gynaecological Cancer Drugs Revenue Market Share by Type (2017-2028)
Figure 38. North America Gynaecological Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 39. North America Gynaecological Cancer Drugs Revenue Market Share by Application (2017-2028)
Figure 40. North America Gynaecological Cancer Drugs Sales Share by Country (2017-2028)
Figure 41. North America Gynaecological Cancer Drugs Revenue Share by Country (2017-2028)
Figure 42. U.S. Gynaecological Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Gynaecological Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Gynaecological Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 45. Europe Gynaecological Cancer Drugs Revenue Market Share by Type (2017-2028)
Figure 46. Europe Gynaecological Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 47. Europe Gynaecological Cancer Drugs Revenue Market Share by Application (2017-2028)
Figure 48. Europe Gynaecological Cancer Drugs Sales Share by Country (2017-2028)
Figure 49. Europe Gynaecological Cancer Drugs Revenue Share by Country (2017-2028)
Figure 50. Germany Gynaecological Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 51. France Gynaecological Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Gynaecological Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Gynaecological Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Gynaecological Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Gynaecological Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Gynaecological Cancer Drugs Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Gynaecological Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Gynaecological Cancer Drugs Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Gynaecological Cancer Drugs Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Gynaecological Cancer Drugs Revenue Share by Region (2017-2028)
Figure 61. China Gynaecological Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Gynaecological Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Gynaecological Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. India Gynaecological Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Gynaecological Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Taiwan Gynaecological Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Gynaecological Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Gynaecological Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Gynaecological Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 70. Philippines Gynaecological Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Gynaecological Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 72. Latin America Gynaecological Cancer Drugs Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Gynaecological Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 74. Latin America Gynaecological Cancer Drugs Revenue Market Share by Application (2017-2028)
Figure 75. Latin America Gynaecological Cancer Drugs Sales Share by Country (2017-2028)
Figure 76. Latin America Gynaecological Cancer Drugs Revenue Share by Country (2017-2028)
Figure 77. Mexico Gynaecological Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 78. Brazil Gynaecological Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 79. Argentina Gynaecological Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Gynaecological Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Gynaecological Cancer Drugs Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Gynaecological Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Gynaecological Cancer Drugs Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Gynaecological Cancer Drugs Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Gynaecological Cancer Drugs Revenue Share by Country (2017-2028)
Figure 86. Turkey Gynaecological Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Gynaecological Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 88. UAE Gynaecological Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 89. Gynaecological Cancer Drugs Value Chain
Figure 90. Gynaecological Cancer Drugs Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed
Buy
